Physician profile
Wael Bitar
NPI 1376747451
$1,087.99
in general payments reported to CMS, 2019-2025
20 companies · $37.43 in 2025
The $37.43 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $28.92 · 2021: $264 · 2022: $460 · 2023: $112 · 2024: $40.86 · 2025: $37.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.49 | 2019-2023 | Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $99.28 | 2021-2023 | |
| Organon LLC | $77.19 | 2022-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $65.39 | 2022-2023 | |
| Scynexis, INC. | $56.21 | 2022 | |
| Lilly USA, LLC | $46.33 | 2021-2022 | |
| Exeltis, USA INC. | $44.32 | 2021-2022 | |
| Biogen, INC. | $40.70 | 2021-2022 | |
| Hologic Sales and Service, LLC | $34.38 | 2024-2025 | Aptima |
| Evofem Biosciences, INC. | $28.27 | 2022 | |
| Heron Therapeutics, INC. | $23.07 | 2022 | |
| Coopersurgical, INC. | $23.01 | 2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $21.52 | 2019 | |
| Minerva Surgical, INC | $20.90 | 2025 | |
| Avion Pharmaceuticals | $18.92 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.86 | 2021 | |
| Aspira Women'S Health INC | $16.69 | 2023 | Ova1 |
| Meditrina | $15.82 | 2022 | |
| Smith+Nephew, INC. | $14.95 | 2019 | |
| Agile Therapeutics, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wael Bitar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.